PharmaSource: The External Manufacturing Community Essential intelligence for biopharma outsourcing leaders | Trusted by 50,000+ professionals | Subscribe TOP STORIES Cellipont Bioservices Supports Six Cell Therapy Projects Targeting 2026 IND Submissions Read More » Northway Biotech Opens $70.94M Cell Therapy CDMO in Lithuania Curia Global Opens $200M Expanded Manufacturing Campus in New Mexico Fortrea Acquires Worldwide Clinical Trials’ Early Phase Division for $45M to Add 200-Bed CPU and GLP Bioanalytical Lab Formosa Pharmaceuticals Files European CTA for TSY-110 Biosimilar ADC Samsung Biologics Publishes PolyPeptide Tender Offer Prospectus Samsung Biologics Plans $2.18B Rights Offering for Growth Strategy Ennolys Expands CDMO Services Across Fermentation and Bioprocessing Evonik Invests $108M in New Lipid-Based Drug Manufacturing Facility in Canada ADC Antibody Drug Conjugates: CDMO Manufacturing Services & Market Report 2026 ADCs vs. AOCs: Shared Design Principles & Key Differences in Bioconjugate Engineering Minapharm, CEPI Partner on Bundibugyo Ebola Vaccine Candidate Artis BioSolutions Launches Genetic Medicines Center in Spain Cell Therapies Releases First Clinical Dose for KOALA CAR T-Cell Trial Centrix Pharma Solutions Partners With University of Sussex on Predictive Modeling 4basebio Expands Genezen Collaboration for Synthetic DNA in Cell and Gene Therapy More news + insights Northway Biotech Opens $70.94M Cell Therapy CDMO in Lithuania Curia Global Opens $200M Expanded Manufacturing Campus in New Mexico Fortrea Acquires Worldwide Clinical Trials’ Early Phase Division for $45M to Add 200-Bed CPU and GLP Bioanalytical Lab PODCASTS “Stop Talking About Resilience in the Future Tense”: What Pharma Actually Wants From CDMOs Abzena on AOCs: Building US Capacity to Compete With China SPOTLIGHT MASTERCLASS: Where Pre-Filled Syringe Tech Transfers Go Wrong RESOURCES Resilience, Risk & Relationships – ExM Leaders Report [DOWNLOAD] Partnerships for an Uncertain World: The CDMO Live Europe 2026 Report Avoiding the Pitfalls: Five Lessons for Cell Therapy Manufacturing Success UPCOMING EVENTS MASTERCLASS: Where Pre-Filled Syringe Tech Transfers Go Wrong AI + Digital Maturity in Contract Manufacturing 2026 External Manufacturing Leaders Basel 2026 External Manufacturing Leaders Dublin 2026
Fortrea Acquires Worldwide Clinical Trials’ Early Phase Division for $45M to Add 200-Bed CPU and GLP Bioanalytical Lab
Fortrea Acquires Worldwide Clinical Trials’ Early Phase Division for $45M to Add 200-Bed CPU and GLP Bioanalytical Lab